While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
In July, the company received $176 million from HHS toward its vaccine efforts. Moderna plans to advance research on the mRNA ...
Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...
Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North ...
Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...
Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and ...